The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Preliminary results of centralized HER2 testing in DCIS of the breast: NSABP B-43.
K. P. Siziopikou
No relevant relationships to disclose
M. A. Cobleigh
Consultant or Advisory Role - Genentech
S. J. Anderson
No relevant relationships to disclose
T. B. Julian
No relevant relationships to disclose
D. W. Arthur
No relevant relationships to disclose
P. Zheng
No relevant relationships to disclose
E. P. Mamounas
Consultant or Advisory Role - Genentech
Honoraria - Genentech
E. R. Pajon
No relevant relationships to disclose
R. J. Behrens
No relevant relationships to disclose
L. Chu
Stock Ownership - Roche
Research Funding - Roche
N. C. Leasure
No relevant relationships to disclose
J. N. Atkins
No relevant relationships to disclose
J. Polikoff
No relevant relationships to disclose
T. E. Seay
No relevant relationships to disclose
W. J. McCaskill-Stevens
No relevant relationships to disclose
R. Rabinovitch
No relevant relationships to disclose
N. Wolmark
Consultant or Advisory Role - Genentech (U)